The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia
|
Children’s Hospital Los Angeles / Markus Muschen |
Innovation Grants |
2008 |
California |
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine / Alice Bertaina, MD/PhD |
Reach Grants |
2019 |
California |
Targeting Childhood Brain Cancer in a Dish to Catalyze New Therapies |
University of California, Davis Medical Center / Paul Knoepfler, PhD |
Innovation Grants |
2017 |
California |
The Identification of Neuroblastoma Cancer Stem Cells.
|
Stanford University / Robert Cho |
Young Investigator Grants |
2007 |
California |
Symptom Burden, Health-Related Quality of Life and Health Care Utilization Among Children Undergoing Hematopoietic Stem Cell Transplantation: Impact of Parent Sleep, Fatigue and Psychological Distress |
Children’s Hospital Los Angeles / Jessica Ward, PhD |
Nurse Researcher Fellowship Grant |
2017 |
California |
The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia |
Children’s Hospital & Research Center at Oakland / Cheryl Peretz, MD |
Young Investigator Grants |
2019 |
California |
Single-cell RNA-seq Profiling of Transcriptional Transition States During Human Retinoblastoma |
Children’s Hospital Los Angeles / Sunhye Lee, PhD |
Young Investigator Grants |
2016 |
California |
Circulating Repetitive Element RNAs as an Osteosarcoma Marker |
Children’s Hospital Los Angeles / David Cobrinik, MD/PhD |
Innovation Grants |
2018 |
California |
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD |
Innovation Grants |
2015 |
California |
Immunotherapeutic Targeting of Stem Cells in Pediatric Brain Tumors
|
Harbor - UCLA Medical Center / Joseph Lasky |
Young Investigator Grants |
2008 |
California |